University of Hertfordshire

• Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity

  Goswami, P., Oliva, E., Ionova, T., Else, R., Kell, J., Fielding, AK., Jennings, DM., Karakantza, M., Al-Ismail, S., Collins, GP., McConnell, S., Langton, C. & Salek, S., 5 Mar 2020, In : Frontiers in Pharmacology. 11, p. 209 209.

  Research output: Contribution to journal › Article

• Factors influencing delays in patient access to new medicines in Canada: a retrospective study of reimbursement processes in public drug plans

  Salek, M-S. S., Hoskyn, S. L., Johns, J., Allen, N. & Sehgal, C., 29 Mar 2019, In : Frontiers in Pharmacology. 10, 13 p., 196.

  Research output: Contribution to journal › Article

• The South African Medicines Control Council: Comparison of Its Registration Process With Australia, Canada, Singapore, and Switzerland

  Keyter, A., Salek, M-S. S., Banoo, S. & Walker, S. R., 14 Mar 2019, In : Frontiers in Pharmacology. 10, p. 1-11 11 p., 228.

  Research output: Contribution to journal › Article

View all »